Comparison Between a Robotic Tele-echo-cardiography Technique and a Standard Echocardiography in the Management of Heart Failure in the Guadeloupe Archipelago Between the University Hospital of Guadeloupe and the Marie-Galante Hospital

Considered as the new global epidemic of the 21st century, heart failure (HF) is a major public health issue. In 2010, the Guadeloupe region already had the highest rate of heart failure deaths in all French departments, furthermore cardiac decompensation of chronic heart failure is the first cardiovascular pathology to be managed in emergency medicine and the first cardiovascular cause of hospitalization. Marie-Galante is an island in the Guadeloupe archipelago, 36% of whose hospital stays are covered by the University Hospital Currently, access to specialized care in Marie-Galante, particularly cardiological care, is very limited with one to two monthly consultations by a specialist cardiologist accessible to a population . Rather, remote echocardiography has been the subject of experimental studies but has not yet been proposed as part of an optimization of the management of a specific cardiovascular disease at separate sites. This is a prospective multicentre study (two cardiologists in private practice of Guadeloupe and one at the Marie-Galante Hospital) interventional cross-over study in which the left ventricular ejection fraction (LVEF) will be the main judgement criterion. Patients will be randomized to determine the order of implementation of the techniques (echocardiography and then teleecardiography or the reverse). In addition, in order to take into account the operator effect, each of the 2 cardiologists will move alternately either for remote echocardiography or to Marie-Galante for in situ echocardiography.

The visit (V1) takes place at Marie-Galante's CH, as soon as possible after inclusion by the generalist practicionner or the cardiologist (V0) and is carried out by the state-registered nurse with a blood sample (biological check-up and biological collection) and ECG Holter place over 24 hours.

• Agreement Between Echocardiography Techniques for Diagnosis of Cardiac Anomalies [Срок оценки: Measured at the second visit (V2) at 2 weeks.]
• Dilated Cardiomyopathy Assessment [Срок оценки: Measured at Visit 2 (V2), 2 weeks after baseline.]
• Quantitative Echocardiographic Measures [Срок оценки: Measured at the second visit (V2) at 2 weeks.]
• Hypertrophic Cardiomyopathy Assessment [Срок оценки: Measured at Visit 2 (V2), 2 weeks after baseline.]
• Valvulopathy Assessment [Срок оценки: Measured at V2 (2 weeks)]
• Systolic Pulmonary Arterial Pressure (PAP) [Срок оценки: Measured at V2 (2 weeks)]
• Left Ventricular Filling Pressure [Срок оценки: Measured at V2 (2 weeks)]
• Duration of Echocardiography [Срок оценки: Measured at the second visit (V2) at 2 weeks.]
• Patient Satisfaction [Срок оценки: Measured at the second visit (V2) at 2 weeks.]